Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,905 | 61,697 | 21,824 | 24,155 | 33,612 |
| Marketable Securities | 90,131 | 52,273 | 53,332 | 68,324 | 62,750 |
| Receivables | N/A | N/A | 969 | 820 | 1,089 |
| TOTAL | $120,631 | $120,163 | $82,372 | $98,226 | $102,634 |
| Non-Current Assets | |||||
| PPE Net | 7,477 | 7,805 | 8,164 | 24,398 | 25,395 |
| Investments And Advances | 22,885 | 43,083 | 10,031 | 10,014 | 23,264 |
| Other Non-Current Assets | 12,453 | 12,571 | 12,939 | 28,912 | 29,132 |
| TOTAL | $42,815 | $63,459 | $31,134 | $63,324 | $77,791 |
| Total Assets | $163,446 | $183,622 | $113,506 | $161,550 | $180,425 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,603 | 1,957 | 1,651 | 2,300 | 5,163 |
| Accrued Expenses | 5,065 | 9,850 | 7,614 | 5,861 | 5,659 |
| TOTAL | $12,628 | $14,787 | $11,937 | $14,638 | $17,173 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,025 | 179 | N/A | 3,332 | 3,926 |
| Other Non-Current Liabilities | 40,782 | 41,546 | 42,295 | 43,055 | 43,647 |
| TOTAL | $47,592 | $49,202 | $50,130 | $47,880 | $48,149 |
| Total Liabilities | $60,220 | $63,989 | $62,067 | $62,518 | $65,322 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,726 | 14,423 | 14,423 | 9,417 | 9,391 |
| Common Shares | 14 | 14 | 9 | 9 | 9 |
| Retained earnings | -422,387 | -403,471 | -383,846 | -333,804 | -315,743 |
| Other shareholders' equity | -189 | 5 | 212 | 214 | 177 |
| TOTAL | $103,226 | $119,633 | $51,439 | $99,032 | $115,103 |
| Total Liabilities And Equity | $163,446 | $183,622 | $113,506 | $161,550 | $180,425 |